PH — Parker-Hannifin Corporation

The market is bullish on PH after Q4 FY2026 adjusted EPS of $9.27 beat consensus by roughly $0.96 and full-year sales hit a record $21.5B. Wall Street has a Buy consensus and recent price targets were raised into the $1,210-$1,358 range. As of 2026-08-27, the day's -2.7% price move and RSI near 49 show some profit-taking and consolidation, but the earnings narrative is clearly positive.

Revenue inflection is clear: quarterly sales went from $5.08B in Sep-2025 to $5.49B in Mar-2026 to $5.76B in Jun-2026, with Q4 FY26 revenue up 9.8% YoY versus only ~1% growth in Q4 FY25. FY26 full-year revenue rose 8.3% reported and 6.6% organic, TTM operating margin improved to ~21.6%, and Q4 GAAP EPS was $8.54 versus $7.15 in Q4 FY25, with adjusted EPS of $9.27. FCF also accelerated to roughly $3.9B in FY26 from $3.3B in FY25. This is not a one-off blip: the $8.5B aerospace backlog and management's raised 30% FY31 margin target point to structural margin and growth upside.

Expensive as of 2026-08-27. TTM P/E is 34.99 versus the 5-year average of 25.99; P/S is 5.93 versus 3.62; P/B is 8.28. On FY27 consensus EPS of $35.12, forward P/E is ~28.8x, still well above the historical average. The 0.84% dividend yield is a minor offset, but the market is paying a premium for the aerospace backlog and margin-expansion story.

At $1,011.20, the price implies roughly $38.90 of EPS at PH's 5-year average P/E of 26x—about 10% above the top of FY27 guidance ($35.25) and above the $35.12 consensus. In other words, the stock is either pricing in sustained better-than-guided earnings or a permanent premium multiple. If FY27 lands near consensus, today's quote requires ~29x earnings; that is achievable if margin expansion continues, but it leaves little room for execution slips.

Neutral/consolidating. As of 2026-08-27, RSI(14) was 49.4, price was 1.9% below the 20-day SMA, 2.1% above the 50-day SMA, and 8.5% above the 200-day SMA. The medium-term uptrend is intact but momentum has stalled near $1,010 after the stock reached $1,099.94 over the past 52 weeks. There is no oversold buy signal or breakout trigger; an entry would look more attractive on a pullback toward the 50-day or a decisive close above $1,040.

• Commercial aerospace upcycle with multi-year double-digit demand and an $8.5B aerospace backlog
• Industrial demand normalizing after destocking, plus reshoring/near-shoring and automation capex tailwinds
• Interest-rate environment: PH's net debt at ~1.4x adjusted EBITDA is manageable, but slower rate cuts could pressure industrial capex and M&A financing
• Clean-tech and efficiency transition, with roughly two-thirds of revenue tied to efficiency-enhancing or clean-tech applications
• Regulatory and approval process for the pending Filtration Group and CIRCOR Aerospace acquisitions

• Q1 FY2027 earnings expected on or around November 5, 2026, providing the first checkpoint on FY27 guidance
• Closing of the Filtration Group and CIRCOR Commercial/Defense Aerospace acquisitions
• Continued conversion of the $12.8B total backlog, especially the $8.5B aerospace backlog
• Progress toward the raised 30% adjusted segment operating margin target by FY2031

• Valuation de-rating: at ~35x trailing and ~28.8x forward earnings, any FY27 guidance cut could compress the multiple sharply
• Aerospace cycle or aftermarket moderation would hit the highest-visibility growth engine
• Integration and execution risk on pending M&A, plus the potential for higher leverage if deals close
• Industrial end-market slowdown or recession could push organic growth below the 5.5%-8.5% FY27 guide

Parker-Hannifin is a high-quality industrial with record results, strong free cash flow, and a credible margin-expansion path. But at $1,011 the stock already trades above my estimate of intrinsic value (~$984) and at a premium to its own history, so the risk/reward is balanced rather than compelling—a good business to own on weakness, not a strong fresh buy at this price.

Calculated by applying a 28.0x forward P/E to FY2027 consensus EPS of $35.12. The multiple is roughly 8% above PH's 5-year average P/E of 25.99, justified by the record aerospace backlog and higher structural margin target, but it is still well below the current 34.99x trailing multiple, producing a fair value of $983.44.